drugset / Trial / NCT00467753
Oxcarbazepine Versus Placebo in Childhood Autism
Completed
5 enrolled
University of Medicine and Dentistry of New Jersey
National Alliance for Research on Schizophrenia and Depression · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The proposed study is designed to assess the effectiveness of treatment with Oxcarbazepine vs. placebo in childhood/adolescent autism. This is a twelve-week study involving twenty subjects between the ages of five and seventeen with a diagnosis of autism.
Timeline
- Start
- 2006-04
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxcarbazepine | Small molecule | 300 mg | — |
| Subject | Oxcarbazepine | Small molecule | 600 mg | — |